Immediate Impact
1 from Science/Nature 59 standout
Citing Papers
Covalent targeted radioligands potentiate radionuclide therapy
2024 StandoutNature
[177Lu]Lu-DOTA-TATE plus long-acting octreotide versus high‑dose long-acting octreotide for the treatment of newly diagnosed, advanced grade 2–3, well-differentiated, gastroenteropancreatic neuroendocrine tumours (NETTER-2): an open-label, randomised, phase 3 study
2024 Standout
Works of Charkes Nd being referenced
MIRD pamphlet No. 17: the dosimetry of nonuniform activity distributions--radionuclide S values at the voxel level. Medical Internal Radiation Dose Committee.
1999
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Charkes Nd | 286 | 199 | 96 | 121 | 18 | 493 | |
| Oscar Tamburrini | 188 | 182 | 71 | 62 | 16 | 536 | |
| G. Arcangeli | 128 | 131 | 141 | 55 | 21 | 486 | |
| Aashish Patel | 107 | 135 | 114 | 24 | 19 | 459 | |
| H. Adams | 105 | 182 | 38 | 30 | 27 | 521 | |
| Myriam Monsieurs | 400 | 167 | 31 | 115 | 21 | 568 | |
| M. G. Stabin | 232 | 198 | 40 | 69 | 17 | 495 | |
| Karin Fischedick | 101 | 475 | 64 | 238 | 23 | 562 | |
| E Furhang | 274 | 192 | 15 | 301 | 20 | 453 | |
| Cylen Javidan-Nejad | 217 | 250 | 14 | 56 | 26 | 549 | |
| G. Garavaglia | 172 | 133 | 58 | 204 | 21 | 534 |
All Works
Loading papers...